Rifamycin Treatment of Tuberculosis in a Patient Receiving Atenolol: Less Interaction with Rifabutin than with Rifampin
Open Access
- 15 August 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (4) , 607
- https://doi.org/10.1086/376648
Abstract
Tuberculosis remains a significant problem, including, and perhaps especially, among persons with other medical problems that require treatment with medicationsKeywords
This publication has 2 references indexed in Scilit:
- A Regimen Containing Rifabutin for the Treatment of Tuberculosis in Patients Intolerant to RifampinClinical Infectious Diseases, 2003
- Therapeutic Implications of Drug Interactions in the Treatment of Human Immunodeficiency Virus‐Related TuberculosisClinical Infectious Diseases, 1999